Lentigen has appointed Tim Ravenscroft as its CEO, replacing company founder Boro Dropulic, who continues to serve as president and CSO.
Before joining Lenitgen, Ravenscroft was president of Bristol-Myers Squibb Medical Imaging. He has also held various management positions at Dupont Pharmaceutical and Glaxo Wellcome.